pharma news today obesity drugs glp-1 october 2025 2024 was a record year for trials and is already poised to take over The future of GLP-1s: Cost,

Yes, early intervention with medications like phentermine is safe when properly monitored

Battelino T, Danne T, Bergenstal RM et al (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range

This imbalance can result from increased free radical production, decreased antioxidant defenses, or both [7]

Recognizing these changes early and addressing them through integrative careincluding peptides , nutritional optimization , and hormone support can make all the difference

Swanepoel T, Mller M, Harvey BH

An antitumor Bis(N-Heterocyclic Carbene)Platinum(II) complex that engages asparagine synthetase as an anticancer target